West Pharmaceutical Services 

€306.95
362
+€0.00+0% Monday 07:00

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
0
本益比
-
股息殖利率
-
股息
-

即將到來

股息

0%股息殖利率
Nov 25
€0.17
Aug 25
€0.17
May 25
€0.17
Feb 25
€0.17
Nov 24
€0.17
10年成長
9.11%
5年成長
7.63%
3年成長
6.54%
1年成長
0.21%

財報

22Oct預期
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
下一步
1.23
1.61
1.99
2.37
預期EPS
2.189895
實際EPS
不適用

財務

20.23%利潤率
有盈利
2017
2018
2019
2020
2021
2022
2.75B營收
555.8M淨利

分析師評級

304.66平均目標價
最高預估為 339.18。
來自過去6個月內的 7 則評分。這不是投資建議。
買入
86%
持有
14%
賣出
0%

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Show more...
執行長
國家
德國
ISIN
US9553061055
WKN
000864330

上市

0 Comments

分享你的想法

FAQ

West Pharmaceutical Services 今天的股價是多少?
WPS.XETRA 目前價格為 €306.95 EUR,過去 24 小時上漲了 +0%。在圖表上更密切關注 West Pharmaceutical Services 股價表現。
West Pharmaceutical Services 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 XETRA Stock Exchange 交易所,West Pharmaceutical Services 的股票以代號 WPS.XETRA 進行交易。
West Pharmaceutical Services 去年的營收是多少?
West Pharmaceutical Services 去年的營收為 2.75BEUR。
West Pharmaceutical Services 去年的淨利是多少?
WPS.XETRA 去年的淨收益為 555.8MEUR。
West Pharmaceutical Services 會發放股息嗎?
是的,WPS.XETRA 的股息每 每季 發放一次。每股最新股息為 0.17 EUR。截至今日,股息殖利率(FWD)% 為 0%。
West Pharmaceutical Services 位於哪個產業?
West Pharmaceutical Services從事於Health & Wellness產業。
West Pharmaceutical Services 何時完成拆股?
West Pharmaceutical Services 最近沒有進行任何拆股。